After a decade of litigation, Johnson and Johsnon has agreed to a settlement deal to resolve the some 69,000 lawsuits alleging the company’s talc-based baby powder caused ovarian cancer and mesothelioma.
Scientists at The Wistar Institute have identified a mechanism behind the chemotherapy resistance that makes ovarian cancer so lethal. The researchers showed that chemotherapy triggers an inflammatory cascade that recruits immune cells into the tumor microenvironment, which ultimately function to protect the cancer from subsequent chemotherapy.
